| Literature DB >> 25049616 |
Y Feng1, X J Yang2, Y B Wang2, W L Li2, Y Liu2, R Q Yin2, J H Yao2.
Abstract
Immune stress is the loss of immune homeostasis caused by external forces. The purpose of this experiment was to investigate the effects of immune stress on the growth performance, small intestinal enzymes and peristalsis rate, and mRNA expression of nutrient transporters in broiler chickens. Four hundred and thirty-two 1-d-old broilers (Cobb500) were randomly assigned to four groups for treatment; each group included nine cages with 12 birds per cage. Group 1 = no vaccine (NV); Group 2 = conventional vaccine (CV); group 3 = lipopolysaccharide (LPS)+conventional vaccine (LPS); group 4 = cyclophosphamide (CYP)+conventional vaccine (CYP). The results demonstrated that immune stress by LPS and CYP reduced body weight gain (BWG), feed intake (FI), small intestine peristalsis rate and sIgA content in small intestinal digesta (p<0.05). However, the feed conversion ratio (FCR) remained unchanged during the feeding period. LPS and CYP increased intestinal enzyme activity, relative expression of SGLT-1, CaBP-D28k and L-FABP mRNAs (p<0.05). LPS and CYP injection had a negative effect on the growth performance of healthy broiler chickens. The present study demonstrated that NV and CV could improve growth performance while enzyme activity in small intestine and relative expression of nutrient transporter mRNA of NV and CV were decreased in the conditions of a controlled rational feeding environment. It is generally recommended that broilers only need to be vaccinated for the diseases to which they might be exposed.Entities:
Keywords: Broilers; Gene Expression; Immune Stress; Intestine Enzyme
Year: 2012 PMID: 25049616 PMCID: PMC4093104 DOI: 10.5713/ajas.2011.11377
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Primer sequences for PCR amplification of target genes
| Target genes | Primer sequences | Predicted size (bp) | Genebank accession |
|---|---|---|---|
| SGLT1 | S:5′-AGCATTTCAGCATGGTGTGTCTTC-3′ | 113 | XM_415247 |
| L-FABP | S:5′-ACTGGCTCCAAAGTAATGACCAATG-3′ | 163 | NM 204192.1 |
| CaBP-D28k | S:5′-TTGGCACTGAAATCCCACTGAA-3′ | 116 | NM 205513.1 |
| β-Actin | S:5′-ATTGTCCACCGCAAATGCTTC-3′ | 86 | NM_205518 |
Effect of different immune stressors on growth performance in broilers1
| Item | Weeks | Treatments | SEM | p value | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| NV | CV | LPS | CYP | ||||
| BWG (kg/bird) | 1–3 | 0.70 | 0.69 | 0.64 | 0.68 | 0.010 | 0.166 |
| 4–6 | 1.53 | 1.44 | 1.37 | 1.41 | 0.015 | 0.001 | |
| 1–6 | 2.23 | 2.13 | 2.01 | 2.09 | 0.022 | 0.001 | |
| FI (kg/bird) | 1–3 | 0.90 | 0.90 | 0.91 | 0.89 | 0.659 | 0.355 |
| 4–6 | 2.90 | 2.79 | 2.69 | 2.70 | 0.152 | 0.026 | |
| 1–6 | 3.80 | 3.69 | 3.59 | 3.60 | 0.329 | 0.004 | |
| FCR | 1–3 | 1.29 | 1.31 | 1.41 | 1.32 | 0.031 | 0.418 |
| 4–6 | 1.89 | 1.93 | 1.97 | 1.93 | 0.032 | 0.103 | |
| 1–6 | 1.59 | 1.62 | 1.69 | 1.63 | 0.009 | 0.184 | |
Each value represents the mean of 9 replicates for each treatment.
BWG = Body weight gain; FI = Feed intake; FCR = Feed conversion ratio.
Means within the same column with different superscripts are significantly different (p<0.05). NV = No vaccine; CV = Conventional vaccine; LPS = Lipopolysaccharide; CYP = Cyclophosphamide.
Effects of immunity stress on small intestinal index in broilers (mg/g)
| Day | Item | Treatments | SEM | p value | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| NV | CV | LPS | CYP | ||||
| 21 d | Duodenum | 0.95 | 0.90 | 0.84 | 0.86 | 0.015 | 0.006 |
| Jejunum | 1.34 | 1.21 | 1.05 | 1.17 | 0.026 | 0.005 | |
| Ileum | 1.05 | 1.10 | 1.26 | 1.19 | 0.039 | 0.232 | |
| 42 d | Duodenum | 0.54 | 0.51 | 0.56 | 0.48 | 0.014 | 0.383 |
| Jejunum | 1.44 | 1.31 | 1.29 | 1.12 | 0.046 | 0.281 | |
| Ileum | 1.15 | 1.00 | 1.10 | 1.00 | 0.045 | 0.720 | |
Each value represents the mean of 9 replicates for each treatment.
Means within the same row column with different superscripts are significantly different (p<0.05).
NV = No vaccine; CV = Conventional vaccine; LPS = Lipopolysaccharide; CYP = Cyclophosphamide.
Effects of immunity stress on digestive enzyme activity in small intestinal digesta (U/mg)
| Enzyme | Item | Treatments | SEM | p value | ||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| NV | CV | LPS | CYP | |||||
| 21 d | Amylase | Duodenum | 187.91 | 140.30 | 220.59 | 233.52 | 15.237 | 0.147 |
| Jejunum | 180.64 | 186.61 | 371.01 | 364.16 | 23.460 | 0.001 | ||
| Ileum | 160.85 | 198.49 | 228.80 | 282.33 | 12.240 | 0.003 | ||
| Lipase | Duodenum | 353.00 | 381.51 | 654.03 | 563.74 | 38.192 | 0.027 | |
| Jejunum | 459.67 | 616.91 | 628.85 | 744.96 | 27.481 | 0.008 | ||
| Ileum | 416.65 | 510.35 | 625.65 | 708.08 | 28.987 | 0.004 | ||
| Trypsin | Duodenum | 79.15 | 75.70 | 80.94 | 86.61 | 1.558 | 0.284 | |
| Jejunum | 85.23 | 90.92 | 101.34 | 99.64 | 1.913 | 0.460 | ||
| Ileum | 82.30 | 87.18 | 93.24 | 95.42 | 3.647 | 0.444 | ||
| 42 d | Amylase | Duodenum | 130.77 | 127.15 | 137.17 | 149.59 | 8.026 | 0.811 |
| Jejunum | 131.18 | 151.62 | 194.21 | 213.94 | 9.148 | 0.006 | ||
| Ileum | 119.61 | 174.98 | 188.33 | 193.73 | 11.552 | 0.045 | ||
| Lipase | Duodenum | 188.53 | 196.47 | 264.74 | 298.66 | 16.000 | 0.084 | |
| Jejunum | 339.01 | 361.93 | 670.34 | 627.05 | 35.595 | 0.001 | ||
| Ileum | 233.08 | 305.66 | 362.42 | 415.50 | 21.731 | 0.025 | ||
| Trypsin | Duodenum | 147.31 | 152.54 | 157.68 | 168.43 | 5.563 | 0.656 | |
| Jejunum | 134.03 | 138.59 | 161.92 | 173.90 | 6.006 | 0.241 | ||
| Ileum | 118.38 | 143.89 | 152.47 | 160.74 | 7.590 | 0.213 | ||
Each value represents the mean of 9 replicates for each treatment.
Means within the same column with different superscripts are significantly different (p<0.05).
NV = No vaccine; CV = Conventional vaccine; LPS = Lipopolysaccharide; CYP = Cyclophosphamide.
Effects of immunity stress on intestinal motility and digesta sIgA in broilers
| Item | Treatments | SEM | p value | |||
|---|---|---|---|---|---|---|
|
| ||||||
| NV | CV | LPS | CYP | |||
| 21 d peristalsis rate (%) | 0.662 | 0.624 | 0.532 | 0.586 | 0.017 | 0.001 |
| 21 d sIgA content (mg/g) | 472.00 | 458.00 | 420.76 | 356.37 | 3.570 | 0.001 |
| 42 d sIgA content (mg/g) | 464.15 | 457.70 | 428.24 | 387.23 | 6.277 | 0.001 |
Each value represents the mean of 9 replicates for each treatment.
Means within the same row with different superscripts are significantly different (p<0.05).
NV = No vaccine; CV = Conventional vaccine; LPS = Lipopolysaccharide; CYP = Cyclophosphamide.
Effects of immunity stress on the relative expression of SGLT1, CaBP-D28k and L-FABP mRNAs in the different parts of intestine
| Day | Gene name | Item | Treatments | SEM | p value | |||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| NV | CV | LPS | CYP | |||||
| 21 d | SGLT1 | Duodenum | 0.89 | 1.04 | 2.02 | 2.64 | 0.664 | 0.006 |
| Jejunum | 0.98 | 0.99 | 1.33 | 1.58 | 0.397 | 0.008 | ||
| Ileum | 0.81 | 0.78 | 1.02 | 1.01 | 0.477 | 0.380 | ||
| CaBP-D28k | Duodenum | 1.12 | 0.84 | 1.17 | 1.89 | 0.124 | 0.068 | |
| Jejunum | 1.02 | 0.93 | 1.40 | 1.45 | 0.174 | 0.002 | ||
| Ileum | 0.87 | 0.97 | 1.38 | 1.54 | 0.953 | 0.099 | ||
| L-FABP | Duodenum | 1.00 | 0.90 | 1.65 | 1.41 | 0.777 | 0.001 | |
| Jejunum | 0.86 | 0.66 | 1.22 | 1.32 | 0.951 | 0.131 | ||
| Ileum | 1.03 | 1.21 | 2.26 | 1.95 | 0.182 | 0.007 | ||
| 42 d | SGLT1 | Duodenum | 1.42 | 0.73 | 1.60 | 1.97 | 0.137 | 0.004 |
| Jejunum | 0.78 | 0.92 | 1.50 | 1.29 | 0.893 | 0.040 | ||
| Ileum | 0.84 | 0.95 | 1.22 | 1.05 | 0.660 | 0.400 | ||
| CaBP-D28k | Duodenum | 1.24 | 0.99 | 2.31 | 1.85 | 0.157 | 0.006 | |
| Jejunum | 1.33 | 1.14 | 2.46 | 2.40 | 0.178 | 0.001 | ||
| Ileum | 1.06 | 1.06 | 1.85 | 1.96 | 0.138 | 0.065 | ||
| L-FABP | Duodenum | 1.14 | 0.85 | 1.96 | 2.02 | 0.176 | 0.050 | |
| Jejunum | 1.28 | 0.82 | 1.86 | 2.10 | 0.155 | 0.020 | ||
| Ileum | 1.27 | 0.81 | 1.31 | 1.53 | 0.106 | 0.087 | ||
Each value represents the mean of 9 replicates for each treatment.
Means within the same row with different superscripts are significantly different (p<0.05).
NV = No vaccine; CV = Conventional vaccine; LPS = Lipopolysaccharide; CYP = Cyclophosphamide.